Ollert, Markus W. PhD
Professor at
Luxembourg Institute of Health
Leading researcher
with 411 publications
in the last 39 years
ORCID:
0000-0002-8055-0103
Updated: 24 March 2022 Professor Dr. med. Markus OLLERT is Director of the Department of Infection and Immunity, Luxembourg Institute of Health (LIH), since September 2014, where he is leading basic and translational research with a focus on immune-related disorders including viral infection, autoimmunity, asthma, allergic rhinitis, anaphylaxis and neurodegeneration. He also holds a position as full professor in Clinical Allergology at Odense University Hospital of the University of Southern Denmark since 2015. He is scientific co-founder of Tolerogenics SàrL, Esch-sur-Alzette, Luxembourg. Academic trajectory – Markus Ollert: Before coming to Luxembourg, he was professor of Molecular Dermatology and Immunology at Technische Universität München (TUM), Munich, Germany, since 2000 and vice-chairman of the clinical Department of Dermatology and Allergy of TUM since 2006. Prof. Ollert pioneered a relevant line of translational research allowing to fill important missing gaps between laboratory research and molecular diagnostic application for patients with severe allergic diseases. He has served as chairperson of the Interest Group (IG) Allergy Diagnosis (IGAD) within the European Academy of Allergy and Clinical Immunology (EAACI), when he initiated the Task Force on Molecular Allergology that published the world’s first comprehensive Users’ Guide on Molecular Allergology with Prof. Ollert as senior author and editor in 2016. Since 2019, Prof. Ollert is member-at-large in the EAACI Executive Committee representing Western and Central Europe. Prof. Ollert is a clinician scientist with board certifications and clinical specializations in Dermatology and in Allergology. Prof. Ollert has published more than 250 articles in scientific journals or text books, of which 223 are listed in PubMed*. His scientific work has been cited more than 13.500-times by scientists around the world with an h-index of 65 in Google Scholar#. During the national effort in Luxembourg against the COVID-19 pandemic, Prof. Ollert has been heading the diagnostic work package (WP04) of the COVID-19 Task Force Research Luxembourg. *PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Ollert+M&sort=date #Google Scholar: https://scholar.google.com/citations?user=9uL0a-cAAAAJ&hl=de Educational and Training activities - Markus Ollert: Until 2022, Prof. Ollert has supervised or co-supervised (1990-2022) more than 50 MD, MD/PhD, PhD candidates or Post-doctoral fellows. Most of his previous fellows have contributed to society with careers in healthcare or science afterwards. Since 2017, Prof Ollert is coordinating the first PhD program in Luxembourg fully dedicated to immunology (NEXTIMMUNE) at the Luxembourg Institute of Health (LIH), with the Universities of Luxembourg (Uni-LU) and Southern Denmark (SDU) as PhD diploma-awarding institutions, bridging between wet lab immunology and computational big data research (funded with >2 Mio. EUR by the Luxembourg National Research Fund FNR) (https://www.lih.lu/page/nextimmune-dtu). Entrepreneurial activities – Markus Ollert: Prof. Ollert co-founded Protein-Ligand-Structural Design (PLS-Design GmbH) in Hamburg, Germany as a start-up of the Universities of Hamburg and of the TUM, Munich in 2004. PLS-Design became a leader in providing molecular diagnostic solutions for patients with severe allergic reactions caused by stinging insects such as honeybees and wasps. The technologies developed by PLS-Design were successfully licensed to diagnostic leaders in the field and are now marketed immunoassays for the diagnosis of insect venom allergy in the product portfolio of ThermoFisher/Phadia, Uppsala, Sweden. In 2016, Prof. Ollert co-founded Tolerogenics SàrL in Esch-sur-Alzette, Luxembourg. Tolerogenics is dedicated to provide solutions for the increasing burden of allergic diseases, which are affecting up to 40% of people in Westernized societies around the world. Tolerogenics wants to contribute to the vision of a world with less
show More
Preview
Evolution over the last 10 years of activity
Aggregated career metrics
411
Total documents
2.74
Normalized Impact
117
Highly Cited Papers (10%)
49.88
International Collab. (%)
Most cited publications
Main coauthors
Following you can review Markus W.'s accomplishments in each of the dimensions.
The perfect present for a young Researcher!
Let's do it!
Dimensions One by One
Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic
attributes.
Each dimension includes a set of indicators and has a especific weight on the One Index.
More information here...
Activity
969
/1000
Reflects an author's research output.
Impact
851
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Excellence
895
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
Leadership
609
/1000
Reflects an author's efforts and commitment in leading research initiatives.
Cooperation
925
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
Openness
921
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.
Community Support
0
/1000
Reflects an author's contributions to the academic community beyond their own research.
Community Recognition
0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
Transference
451
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
Fundraising
0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
All indicators
Performance
Activity
Reflects an author's research output.
| Documents | 411 | Count of all document types. |
|---|---|---|
| Docs/Year | 10.54 | Average of documents published by author per year. |
| Citable docs | 344 | Count of journal articles, proceeding papers and reviews. |
| Journal Articles | 315 | Documents published as articles in scientific journals usually peer-reviewed. |
| Conferences | 0 | Original article reporting data presented at a conference or symposium. |
| Reviews | 29 | Review papers authored by the researcher. |
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
| Theses | 0 | Document submitted in support of candidature for an academic degree or professional qualification presenting the author's research and findings |
| Books | 0 | A whole monograph or the entire book. |
| Book Chapters | 0 | Complete chapter in a book or book series volume where the item is identified as a chapter by a heading or section indicator. |
| Datasets | 7 | Number of dataset where the author have contributed to the creation. |
| Editorials | 3 | Papers where the author contributed editorial content. |
| Reports | 0 | Research reports or white papers authored. |
| Grants | 0 | Research projects funded through external grants awarded to the author. |
| Pre-Prints | 25 | Number of publications freely available in pre-print format. |
| Clinical Trials | N/A | Number of clinical trials where the author has participated. |
| Other types | 0 | Other type of documents. |
Impact
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citations | 14761 | Total number of citations to all the publications attributed to the author (all types). |
|---|---|---|
| Self Citations | 741 | Citations where the author references their own previous work. |
| Self Citation Rate | 5.02 | Percentage of self-citations in the author's total citation count. |
| Non Self Citation Rate | 94.98 | Percentage of citations received from sources that are not self-citations. |
| Hot Citations | 734 | Total number of citations recieved in the last 6 months. |
| Citations/Document | 35.91 | Average of citations recieved per document. |
| % Not Cited | 0.0 | Percentage of documents with no citations recieved. |
| Relative Citation Index | 2.741 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and discipline. An author's RCI corresponds to the average of the values of his/her publications. |
| Journal Relative Citation Index | 2.475 | Item oriented indicator consisting of the quotient between the number of citations to a given work and the average number of citations to works of the same type, year and journal. An author's RCI corresponds to the average of the values of his/her publications. |
| H Index | 65 | Maximum value of h such that the given author has published at least h papers that have each been cited at least h times. |
| G Index | 110 | Maximum value of g such that the given author has published at least g papers that have each been cited at least g^2 times. |
| i10 Index | 199 | Number of documents with at least 10 citations recieved. |
Excellence
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.
| Citation Score | 0.621 | Ratio between 0 and 1 being 0 corresponding to the citation percentile being 0 the 0th and 1 the 100th. |
|---|---|---|
| Citation Normalized Percentile | 0.607 | Citation percentile normalized to 1 (0 worst, 1 best) of the position in citations rankin within the field. Provided by OpenAlex. |
| Higly Cited Papers (top 10%) | 117 | Count of publications falling on or above the 90th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Higly Cited Papers | 2.847 | Quotient between the real number of Highly Cited Papers (HCP) and expected number of HCP's that is the 10% of total documents. |
| Outstanding Papers (top 1%) | 15 | Count of publications falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
| Relative Outstanding Papers | 3.65 | Quotient between the real number of Outstanding Papers (OP) and expected number of OP's that is the 1% of total documents. |
| Outstanding Papers (top 0.1%) | 2 | Count of publications falling on or above the 99.9th citation percentile in the cohort of publications of the same type, year and discipline. |
| Hot Papers | 15 | Using only the citations recieved in the last 6 months: documents falling on or above the 99th citation percentile in the cohort of publications of the same type, year and discipline. |
Interaction within community
Leadership
Reflects an author's efforts and commitment in leading research initiatives.
| Docs Leadership | 78 | Number of documents lead by the author. |
|---|---|---|
| % Leadership | 18.98 | Percentage of documents lead by the author. |
| Docs International Leadership | 23 | Number of documents in international collaboration lead by the author. |
| % International Leadership | 5.6 | Percentage of documents in international collaboration lead by the author. |
| Principal Investigator | 0 | Number of times where the author served as the lead researcher in a project. |
| Associations Founded | 0 | Number of associations founded by the author. |
| Societies Founded | 0 | Number of scientific or professional societies established by the author. |
| Foundations Founded | 0 | Number of research-related foundations established by the author. |
| Councils | 0 | Number of councils founded by author. |
Cooperation
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.
| Authors/Paper | 22.41 | Average number of authors per document. |
|---|---|---|
| % Highly Authored Papers | 19.46 | Percentage of documents with 25 or more authors. |
| Countries/Paper | 3.27 | Average number of different countries in the author's affiliation line per document. |
| Docs International Collaboration | 205 | Number of documents reporting two or more different countries in the author's affiliation line. |
| % International Collaboration | 49.88 | Percentage of documents reporting two or more diffetent countries in the author's affiliation line. |
Community Support
Reflects an author's contributions to the academic community beyond their own research.
| Peer Review Counts | 1 | Number of times the author peer-reviewed publications. |
|---|---|---|
| Society Membership | 0 | Number of societies of wich the author is a member. |
| Society Memberships | 0 | Memberships held by the author in scientific or professional societies. |
| Editorial Board Memberships | 0 | Number of journals where the author has been member of editorial board. |
| Panelists | 0 | Number of times the author have been a panelist in the European Research Council (ERC) calls. |
Community Recognition
Reflects the academic community's acknowledgment and appreciation of an author's contributions.
| Distinctions | 0 | Number of times the author have recieved a distinction for its career. |
|---|---|---|
| Invitations | 0 | Number of times the author has been invited to talks, professorships, expositions or demonstrations. |
| Talks | 0 | Number of times the author has been invited to talks. |
| Professorships | 0 | Number of times the author has been invited to professorhips. |
| Commissioned Reports | 0 | Commissioned reports done by the author. |
Interaction with society
Openness
Reflects an author's commitment to making their research freely accessible and open to the public.
| Open Access Documents | 233 | Number of documents in Open Access mode. |
|---|---|---|
| % Open Access Documents | 56.69 | Percentage of documents in Open Access mode. |
| Open Access Gold | 70 | Number of documents published in an OA journal that is indexed by the DOAJ. |
| Open Access Green | 54 | Toll-access on the publisher landing page, but there is a free copy in an OA repository. |
| Open Access Hybrid | 38 | Free under an open license in a toll-access journal. |
| Open Access Bronze | 70 | Free to read on the publisher landing page, but without any identifiable license. |
| Open Access Closed | 178 | Non Open Access documents. |
Transference
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.
| Patents | 0 | Intellectual property that gives its owner the legal right to exclude others from making, using, or selling an invention for a limited period of time in exchange for publishing an enabling disclosure of the invention. |
|---|---|---|
| Advisory Boards | 0 | Number of advisory boards of which the author is member. |
| Companies | 0 | Number of companies created or founded by the author. |
Fundraising
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.
| Funding Counts | 0 | Number of activities reported as funding recieved. |
|---|---|---|
| ERC Grantees | 0 | Researchers awarded grants from the European Research Council. |